Articles related to MEDICARE

Retina practices are adjusting after Good Days funding limitations reduced copay support for some patients requiring chronic anti-VEGF therapy. Medicare Advantage patients appear especially exposed to affordability pressure.

Medicare’s new GLP-1 Bridge Program expands lower-cost access to certain weight-loss medications for eligible beneficiaries. Concurrent ISMP guidance outlines common medication errors and counseling challenges as more patients initiate GLP-1 therapy.

Video-based ADHD prescribing increased substantially following Australia’s permanent telehealth reforms, with ADHD consultations showing greater virtual adoption than other psychotropic prescribing categories. Observational findings describe utilization patterns but do not establish causality.

According to Elizabeth Cifers, MBA, a practice management consultant specializing in retina practice: “The key is to focus on medical necessity for the information the test will provide, rather than ordering an OCTA routinely.”

“Patients hospitalized for HFrEF in US clinical practice are at very high risk of poor clinical outcomes, even when prescribed quadruple medical therapy.” — Dr. Stephen J. Greene, Duke Clinical Research Institute

“Patients and doctors [lack] enough research to inform medical guidelines and many patients are using these products without talking to their doctor about them.” —Senior White House official